Delivery Order SPE2DB22D1017-SPE2DB25FF3NQ
Award Date
1/21/25
Potential Completion Date
1/22/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $14,688.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENTS, a medical product, with a performance period ending on December 15, 2023. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with ID SPE2DB22D1202|SPE2DB25FUJP2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,514.66 Firm Fixed Price delivery order is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,121.40 firm-fixed-price delivery order is for the supply of ABRYSVO vials with diluent syringes, with a period of performance through October 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $13,798.13 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a pharmaceutical product. This Delivery Order is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,762.97 firm fixed-price delivery order is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, medical supplies used in federal healthcare programs. The contract has an ultimate completion date of March 18, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $22,915.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the provision of ABRYSVO VIAL WITH DILUENTS, a medical commodity. This IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for...
This federal contract award, with an ID of SPE2DB25D3201|SPE2DB25FNQZH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,002.40 firm fixed-price delivery order is for the supply of "ABRYSVO VIAL WITH DILUENT SYRGS", a medical product, with a completion date of February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FFG92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,194.50 firm fixed-price delivery order is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, to support defense healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,370.80 Firm Fixed Price Delivery Order contract is for the supply of ABRYSVO VIAL WITH DILUENTS, a medical product, with a completion date of July 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $10,482.55 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565931324 ABRYSVO VIAL WITH DILUENT SYRGS. This product is a medical supply used to support military treatment programs and facilities worldwide. The contract has a firm fixed price and an ultimate completion date of September 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...